The Atrial Fibrillation Association in the UK was shocked by the decision by the National Institute for Health and Clinical Excellence (NICE) to deny atrial fibrillation patients access to dronedarone, a medication that has been approved in the U.S. and Europe. AFA is conducting a campaign to make the voices of atrial fibrillation patients heard. …
Read More
At Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy shared with us some of the new atrial fibrillation catheter ablation techniques and also talked about non-pharmacological approaches to afib stroke prevention. See the video: Interview with Dr. Vivek Reddy at Boston Atrial Fibrillation Symposium 2010
Read More
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial …
Read More
At Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Natale shared with us some of the new directions in atrial fibrillation treatment, including the newer hybrid procedures combining catheter ablation and surgery for chronic or persistent atrial fibrillation, and contact force sensing. See the video: Interview with Dr. Andrea Natale at Boston Atrial Fibrillation Symposium 2010
Read More
Boston Atrial Fibrillation Symposium will be this week, so watch for great info about the latest in atrial fibrillation causes and risk factors, and afib treatments, including medication, catheter ablation, and surgery. If you're going, please let me know so we can meet. StopAfib will be tweeting again from Boston Afib (1/14/10-1/16/10), so please follow …
Read More